Aspirin to prevent problems in people on dialysis
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies whether taking aspirin can reduce heart and clot-related complications in adults receiving long-term dialysis. It may help by improving blood clotting behavior, but it also requires that aspirin is safe for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and currently on dialysis, either new or ongoing.
- Your dialysis is expected to continue as long-term maintenance therapy.
- A doctor can offer aspirin safely for you (no aspirin allergy or safety concerns).
- You do not need certain blood thinners or clot-preventing medicines (like aspirin/other antiplatelet drugs or warfarin/NOACs) based on your doctor’s judgment.
- You do not have a recent history of bleeding in the brain (including hemorrhagic stroke or intracranial bleeding in the past 12 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a low dose of aspirin can protect the kidneys in people with early diabetic kidney disease. It aims to see if aspirin slows down kidney damage without causing serious side effects.
This study checks how aspirin (also called salicylate) affects how platelets work, which helps blood clot. It involves people with advanced chronic kidney disease who are treated with Aranesp, and it may help guide safer care.
This trial compares two types of blood thinners (vitamin K antagonists and factor Xa inhibitors) versus no blood thinner in people with atrial fibrillation who are on dialysis or have very advanced kidney disease. It aims to see which option is safest and most effective for preventing strokes and bleeds.
This study tests how safe a specific blood thinner called “citrate” is when used during continuous kidney dialysis (CRRT) for people with AKI or kidney failure. If you qualify, your care team will compare citrate safety against standard approaches to see if it’s tolerable and safe.
This study compares two ways to manage atrial fibrillation (an irregular heartbeat) in people on dialysis. One approach uses a blood thinner called apixaban, and the other does not use blood thinners. The goal is to see which approach better prevents strokes and bleeding.
This trial studies whether the blood thinner warfarin is safe and effective for preventing stroke and blood clots in people who have atrial fibrillation and need long-term dialysis. It may help your care team better balance clot prevention against bleeding risk.
Hear when a new CKD (Chronic Kidney Disease) Stage 5D trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.